While this class of drugs was initially approved for type 2 diabetes, it has recently gained global attention for cardiovascular risk reduction and weight loss in patients with obesity, irrespective of the presence of diabetes
Back Jin, T (May 2023) 'Tirzepatide, a new class of incretin-based drug for diabetes' , Obesity Medicine , 39, 1000483
Heres a more detailed look at each treatment and how they work: 1
The obtained results in this study revealed that neoplasia, tumor growth, and metastasis can be delayed by vitamin D (136)
While other products on our list have merits, The Protect offers the most complete glutathione solution for Australians seeking optimal antioxidant protection and longevity support